Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.

Rajakumar T. et al, (2021), Future Oncol, 17, 1083 - 1095

Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management

Ranasinha N. et al, (2021), BJUI Compass, n/a

The multiple effects of aspirin in prostate cancer patients.

Joshi SN. et al, (2020), Cancer Treat Res Commun, 26

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.

Philippou Y. et al, (2020), Br J Cancer, 123, 1089 - 1100

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Hamdy FC. et al, (2020), Health Technol Assess, 24, 1 - 176

Prescribing patterns for medical treatment of suspected prostatic obstruction: A spatiotemporal statistical analysis of Scottish open access data

Andreis F. et al, (2020)

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Cappuccini F. et al, (2020), J Immunother Cancer, 8

Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Sathianathen NJ. et al, (2020), Eur Urol

Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.

Rao SR. et al, (2020), J Mol Diagn, 22, 652 - 669

Harnessing the potential of multimodal radiotherapy in prostate cancer.

Philippou Y. et al, (2020), Nat Rev Urol

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.

Neal DE. et al, (2020), Eur Urol, 77, 320 - 330

Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit- The "Fry-Turnbull" Effect.

Lovegrove CE. et al, (2020), BJU Int

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.

Bryant RJ. et al, (2020), BJU Int

Re: Pembrolizumab for Treatment-refractory Metastatic Castration-resistant Prostate Cancer: Multicohort, Open-label Phase II KEYNOTE-199 Study

Philippou Y. et al, (2020), European Urology

VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer

(2019), Journal of Clinical Oncology

Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis.

Elwenspoek MMC. et al, (2019), JAMA Netw Open, 2

Testicular cancer in men with undescended testis: Insights from the Thames Valley Testicular Cancer database

(2019), Journal of Clinical Urology

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X. et al, (2019), Prostate, 79, 1079 - 1089

Anti-androgens regulate amino acid-mTORC1 signalling and extracellular vesicle secretion to modulate prostate cancer progression

McCormick K. et al, (2019), CLINICAL & EXPERIMENTAL METASTASIS, 36, 167 - 167

Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.

Bryant RJ. et al, (2019), J Urol, 201, 510 - 519

Load More

Include forthcoming?